Clinical Trials Logo

Healthy Volunteers clinical trials

View clinical trials related to Healthy Volunteers.

Filter by:

NCT ID: NCT00767455 Completed - Healthy Volunteers Clinical Trials

Cumulative Irritation Potential of 828 Ointment

Start date: October 2008
Phase: Phase 1
Study type: Interventional

Cumulative Irritation Patch Test

NCT ID: NCT00767052 Completed - Healthy Volunteer Clinical Trials

Investigate the Safety Tolerability and Pharmacokinetics of Multiple Doses of AZD1236

Start date: September 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to investigate the safety, tolerability and pharmacokinetics of multiple ascending oral doses of AZD1236 given to healthy young subjects for 13 days and to evaluate the single-dose relative bioavailability of the oral suspension and oral tablet formulations.

NCT ID: NCT00765492 Completed - Healthy Volunteer Clinical Trials

AZD8529 Multiple Ascending Dose Study in Healthy Subjects

Start date: October 2008
Phase: Phase 1
Study type: Interventional

This is a study to evaluate safety, tolerability, PK and PD effects of orally administered AZD8529 after multiple ascending doses

NCT ID: NCT00761501 Completed - Healthy Volunteer Clinical Trials

Phase I Study to Evaluate Bioavailability of Naproxen as PN400 Compared to Naproxen as Proxen S and Naprosyn E

Start date: September 2008
Phase: Phase 1
Study type: Interventional

The purpose of the study is to investigate the uptake in the body of naproxen; one of the two active substances in PN400. We also want to show that the body's uptake of naproxen given as PN400 is comparable to that of currently marketed naproxen tablets.

NCT ID: NCT00758433 Completed - Healthy Volunteers Clinical Trials

Civamide Patch Safety, Tolerability and PK Study

Start date: September 2008
Phase: Phase 1
Study type: Interventional

To evaluate the tolerability of two different strengths of a Civamide Patch (0.0075% and 0.0150%) compared to the placebo patch and each other in healthy adult volunteers. To assess the pharmacokinetics of civamide and to determine if there is systemic absorption of the drug from civamide patch in a subset of study subjects.

NCT ID: NCT00757042 Completed - Healthy Volunteers Clinical Trials

Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis

Start date: September 18, 2008
Phase: Phase 1
Study type: Interventional

This study is a single dose escalation study of tezepelumab (AMG 157) in healthy adults (Part A) and adults with moderate to severe atopic dermatitis (Part B). The purpose of the study is to evaluate the safety, tolerability, immunogenicity and pharmacokinetics of tezepelumab.

NCT ID: NCT00756860 Completed - Healthy Volunteers Clinical Trials

A Phase 1 Multiple Dose Study to Compare the Effects of AMG 223 and Sevelamer HCL (Renagel®)

Start date: May 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to determine if subjects on 2g AMG 223 will achieve 60% or greater reduction in urinary phosphorus from baseline compared to subjects on 2g Renagel®. Renagel®, Sevelamer HCl is currently the market leader for the treatment of hyperphosphatemia in patients on dialysis.

NCT ID: NCT00755378 Completed - Healthy Volunteer Clinical Trials

AZD8529 Single Ascending Dose Study

SAD
Start date: September 2008
Phase: Phase 1
Study type: Interventional

This is a study to evaluate safety, tolerability, PK and PD effects of orally administered AZD8529 after single ascending doses

NCT ID: NCT00752141 Completed - Healthy Volunteers Clinical Trials

Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers

Start date: September 2008
Phase: Phase 1
Study type: Interventional

The purpose of this study is to explore the possible cognitive effects of oxybutynin tablets and oxybutynin gel.

NCT ID: NCT00750802 Completed - Healthy Volunteer Clinical Trials

A Sedation/Cognition/EEG Study Using AZD6280 and Comparator

Start date: September 2008
Phase: Phase 1
Study type: Interventional

The purpose of the study is to determine the effects of AZD6280 compared to lorazepam on sleepiness, concentration and brain activity.